BIOMAT Database Logo BIOMAT Database Logo

Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis. 1998

M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Department of Tumour Biology, Institute of Medical Science, University of Tokyo, Japan.

In order to clarify the role of cytotoxic T lymphocytes (CTL) in hepatitis C virus (HCV) infection, an HLA-B35-restricted cytotoxic T cell epitope of HCV was identified using a strategy called reverse immunogenetics. Twenty-eight of 53 HCV peptides carrying two anchor residues were selected as HLA-B*3501 binding peptides. These peptides were used to induce the specific cytotoxic T cells in peripheral blood lymphocytes from a patient with acute hepatitis C. Six HLA-B*3501 binding peptides induced the peptide-specific CTL. One (HPNIEEVAL) of five peptides was confirmed as the epitope by the specific T cell clones. A sequence identical to the epitope was detected in isolates of the virus from the patient and a strong CTL response to this epitope was observed in the acute phase of hepatitis C but not in the recovery phase. The specific CTL for this epitope were not detected in peripheral blood lymphocytes from patients with chronic hepatitis C. Together these results suggest that the CTL specific for this epitope have an important role in the elimination of the virus in the patient.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015797 HLA-B35 Antigen A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*35 allele family. HLA Class I Histocompatibility Antigen, B-35 alpha Chain,HLA-B35,Antigen, HLA-B35,HLA B35 Antigen,HLA Class I Histocompatibility Antigen, B 35 alpha Chain
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017951 Antigen Presentation The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989) Antigen Processing,Antigen Presentations,Antigen Processings
D018604 Epitope Mapping Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry. Epitope Mappings,Mapping, Epitope,Mappings, Epitope

Related Publications

M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
June 2001, Journal of hepatology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
June 1997, AIDS (London, England),
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
March 1993, The Journal of experimental medicine,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
June 2012, International immunopharmacology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
April 2001, Journal of virology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
January 1996, Journal of virology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein.
December 1995, The Journal of general virology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
February 2001, Journal of hepatology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope.
July 2007, Journal of virology,
M Ibe, and T Sakaguchi, and K Tanaka, and S Saito, and S Yokota, and T Tanaka, and K Shimotohno, and Y Chujoh, and Y Shiratori, and M Omata, and K Miwa, and M Takiguchi
HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
November 1993, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!